‘A Randomised Trial of the Effect and Cost-Effectiveness of Early Intensive Mulitfactorial Therapy on 5-Year Cardiovascular Outcomes in Individuals with Screen-Detected Type 2 Diaberes:The Anglod-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) Study.’ n. pag. Web. <http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-64#abstract>.
Amori, Renee E., Joseph Lau, and Anastassios G. Pittas. ‘Efficacy and Safety of Incretin Therapy in Type 2 Diabetes’. JAMA 298.2 (2007): n. pag. Web.
Amy Kennedy. ‘Does Exercise Improve Glycaemic Control in Type 1 Diabetes? A Systematic Review and Meta-Analysis’. PLoS ONE 8.3 (2013): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598953/>.
Anthony H. Barnett, Jenny Grice. New Mechanisms in Glucose Control. BMJ Books; 1 edition, 2013. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://lib.myilibrary.com?id=478133>.
‘[ARCHIVED CONTENT] Medicines Management: Everybody’s Business : Department of Health - Publications and Statistics’. N.p., n.d. Web. <http://webarchive.nationalarchives.gov.uk/20080205132320/http:/dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_082200>.
Atkinson, M. A. ‘The Pathogenesis and Natural History of Type 1 Diabetes’. Cold Spring Harbor Perspectives in Medicine 2.11 (2012): a007641–a007641. Web.
Avery, L. et al. ‘Changing Physical Activity Behavior in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Behavioral Interventions’. Diabetes Care 35.12 (2012): 2681–2689. Web.
Bailey, Clifford J et al. ‘Effect of Dapagliflozin in Patients with Type 2 Diabetes Who Have Inadequate Glycaemic Control with Metformin: A Randomised, Double-Blind, Placebo-Controlled Trial’. The Lancet 375.9733 (2010): 2223–2233. Web.
Bailey, Stephen. Academic Writing : A Handbook for International Students. N.p. Web. <http://lib.myilibrary.com.ezproxy4.lib.le.ac.uk/Open.aspx?id=310467>.
Barry, Vaughn W. et al. ‘Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis’. Progress in Cardiovascular Diseases 56.4 (2014): 382–390. Web.
Bennett, Wendy L. et al. ‘Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations’. Annals of Internal Medicine 154.9 (2011): n. pag. Web.
Bergenstal, Richard M. et al. ‘Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes’. New England Journal of Medicine 363.4 (2010): 311–320. Web.
Bethel, M. Angelyn et al. ‘Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)’. Diabetes Care 40.4 (2017): 494–501. Web.
Beverley M Shields. ‘Can Clinical Features Be Used to Differentiate Type 1 from Type 2 Diabetes? A Systematic Review of the Literature’. BMJ Open 5.11 (2015): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636628/?report=classic>.
Birkeland, Kåre I. ‘Hyperglycaemia in Pregnancy: Still a Lot to Learn’. The Lancet Diabetes & Endocrinology 3.10 (2015): 752–753. Web.
Brown, Julie et al. ‘Lifestyle Interventions for the Treatment of Women with Gestational Diabetes’. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd, 1996. Web. <http://doi.wiley.com/10.1002/14651858.CD011970.pub2>.
Buse, J. B. et al. ‘DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks’. Diabetes Care 33.6 (2010): 1255–1261. Web.
Buse, John B et al. ‘Liraglutide Once a Day versus Exenatide Twice a Day for Type 2 Diabetes: A 26-Week Randomised, Parallel-Group, Multinational, Open-Label Trial (LEAD-6)’. The Lancet 374.9683 (2009): 39–47. Web.
Buse, John B. et al. ‘Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes’. Annals of Internal Medicine 154.2 (2011): n. pag. Web.
‘Canagliflozin, Dapagliflozin and Empagliflozin as Monotherapies for Treating Type 2 Diabetes | 1-Recommendations | Guidance and Guidelines | NICE’. n. pag. Web. <https://www.nice.org.uk/guidance/ta390/chapter/1-Recommendations>.
Capehorn, M. et al. ‘Challenges Faced by Physicians When Discussing the Type 2 Diabetes Diagnosis with Patients: Insights from a Cross-National Study (IntroDia                              )’. Diabetic Medicine (2017): n. pag. Web.
Chimen, M. et al. ‘What Are the Health Benefits of Physical Activity in Type 1 Diabetes Mellitus? A Literature Review’. Diabetologia 55.3 (2012): 542–551. Web.
Choudhary, Pratik et al. ‘Islet Cell Transplantation: Current Status in the UK (2012)’. Practical Diabetes 29.7 (2012): 280–285. Web.
‘Constructs of Depression and Distress in Diabetes: Time for an Appraisal- ClinicalKey’. N.p., n.d. Web. <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858715001357>.
‘Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus (Review) TA151, July 2008’. N.p., n.d. Web. <http://www.nice.org.uk/guidance/ta151>.
Copeland, K. C. et al. ‘Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents’. PEDIATRICS 131.2 (2013): 364–382. Web.
Courtney, Hamish et al. ‘Long-Term Management of Type 2 Diabetes with Glucagon-like Peptide-1 Receptor Agonists’. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Volume 10 (2017): 79–87. Web.
Creme, Phyllis, and Mary R. Lea. Writing At University: A Guide For Students. 3rd ed. Maidenhead: McGraw-Hill Education, 2008. Web. <https://ebookcentral.proquest.com/lib/leicester/detail.action?pq-origsite=primo&amp;docID=345134>.
‘Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes June 2013’. N.p., n.d. Web. <http://www.nice.org.uk/guidance/ta288>.
Davies, M. et al. ‘Introduction of Biosimilar Insulins in Europe’. Diabetic Medicine 34.10 (2017): 1340–1353. Web.
Davies, M J et al. ‘Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) Programme for People with Newly Diagnosed Type 2 Diabetes: Cluster Randomised Controlled Trial’. BMJ 336.7642 (2008): 491–495. Web.
Dhatariya, K. K., C. Skedgel, and R. Fordham. ‘The Cost of Treating Diabetic Ketoacidosis in the UK: A National Survey of Hospital Resource Use’. Diabetic Medicine 34.10 (2017): 1361–1366. Web.
‘Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period  (NG3’. N.p., n.d. Web. <https://www.nice.org.uk/guidance/ng3>.
‘Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults | Guidance and Guidelines | NICE’. n. pag. Web. <https://www.nice.org.uk/guidance/cg15>.
Diamant, Michaela et al. ‘Once Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3): An Open-Label Randomised Trial’. The Lancet 375.9733 (2010): 2234–2243. Web.
Dungan, Kathleen M et al. ‘Once-Weekly Dulaglutide versus Once-Daily Liraglutide in Metformin-Treated Patients with Type 2 Diabetes (AWARD-6): A Randomised, Open-Label, Phase 3, Non-Inferiority Trial’. The Lancet 384.9951 (2014): 1349–1357. Web.
‘Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists  in Type 2 Diabetes  Systematic Review and Mixed-Treatment Comparison Analysis’. n. pag. Web. <http://onlinelibrary.wiley.com.ezproxy3.lib.le.ac.uk/doi/10.1111/dom.12849/epdf>.
‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’. New England Journal of Medicine 375.18 (2016): 1799–1802. Web.
‘Exenatide Prolonged-Release Suspension for Injection in Combination with Oral Antidiabetic Therapy for the Treatment of Type 2 Diabetes | Guidance and Guidelines TA 248 Feb 2015’. N.p., n.d. Web. <https://www.nice.org.uk/guidance/ta248>.
‘Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring’. Journal of diabetes science and technology (Online) 3.4 n. pag. Web. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769951/>.
Fagin, James A., and Samuel A. Wells. ‘Biologic and Clinical Perspectives on Thyroid Cancer’. New England Journal of Medicine 375.11 (2016): 1054–1067. Web.
Ferrari, M., M. Dal Cin, and M. Steele. ‘Self-Compassion Is Associated with Optimum Self-Care Behaviour, Medical Outcomes and Psychological Well-Being in a Cross-Sectional Sample of Adults with Diabetes’. Diabetic Medicine 34.11 (2017): 1546–1553. Web.
Gale, Edwin AM. ‘Is Type 2 Diabetes a Category Error?’ The Lancet 381.9881 (2013): 1956–1957. Web.
Gallwitz, Baptist et al. ‘2-Year Efficacy and Safety of Linagliptin Compared with Glimepiride in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Randomised, Double-Blind, Non-Inferiority Trial’. The Lancet 380.9840 (2012): 475–483. Web.
Grammes, J. et al. ‘Focus Group Study to Identify the Central Facets of Fear of Hypoglycaemia in People with Type 2 Diabetes Mellitus’. Diabetic Medicine (2017): n. pag. Web.
Gray, L. J. et al. ‘Implementation of the Automated Leicester Practice Risk Score in Two Diabetes Prevention Trials Provides a High Yield of People with Abnormal Glucose Tolerance’. Diabetologia 55.12 (2012): 3238–3244. Web.
Gray, L.J. et al. ‘External Validation of Two Diabetes Risk Scores in a Young UK South Asian Population’. Diabetes Research and Clinical Practice 104.3 (2014): 451–458. Web.
Green, Jennifer B. et al. ‘Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes’. New England Journal of Medicine 373.3 (2015): 232–242. Web.
Gregg, Edward W. ‘The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016’. Diabetes Care (2017): n. pag. Web.
‘Guidelines’. N.p., n.d. Web. <https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes>.
Hadjiconstantinou, Michelle et al. ‘Do Web-Based Interventions Improve Well-Being in Type 2 Diabetes? A Systematic Review and Meta-Analysis’. Journal of Medical Internet Research 18.10 (2016): n. pag. Web.
Harman-Boehm, Ilana. ‘Continuous Glucose Monitoring in Type 2 Diabetes’. Diabetes Research and Clinical Practice 82 (2008): S118–S121. Web.
Hartman, Yvonne A.W. et al. ‘Insulin-Associated Weight Gain in Type 2 Diabetes Is Associated With Increases in Sedentary Behavior’. Diabetes Care 40.9 (2017): e120–e121. Web.
Heinonen, I et al. ‘Sedentary Behaviours and Obesity in Adults: The Cardiovascular Risk in Young Finns Study’. BMJ Open 3.6 (2013): n. pag. Web.
Henson, Joseph. ‘Associations of Sedentary Time with Fat Distribution in a High-Risk Population.’ (2014): n. pag. Web. <https://lra.le.ac.uk/handle/2381/32505>.
Hessler, D. M. et al. ‘Diabetes Distress Is Linked with Worsening Diabetes Management over Time in Adults with Type 1 Diabetes’. Diabetic Medicine 34.9 (2017): 1228–1234. Web.
Holt, Richard I. G. et al. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
---. Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated, 2016. Web. <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>.
---. Textbook of Diabetes. 4th ed. Chichester: Wiley-Blackwell, 2010. Web. <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>.
Inzucchi, Silvio E. et al. ‘Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes’. Diabetes Care 38.1 (2015): 140–149. Web.
Jelinek, Herbert F. et al. ‘Data Analytics Identify Glycated Haemoglobin Co-Markers for Type 2 Diabetes Mellitus Diagnosis’. Computers in Biology and Medicine 75 (2016): 90–97. Web.
John M Jakicic. ‘Physical Activity Considerations for the Treatment and Prevention of Obesity’. The American Journal of Clinical Nutrition 82.1 (2005): 226S-229S. Web. <http://ajcn.nutrition.org/content/82/1/226S>.
Johnston, Bradley C. et al. ‘Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults’. JAMA 312.9 (2014): n. pag. Web.
Jones, A. G., and A. T. Hattersley. ‘The Clinical Utility of C-Peptide Measurement in the Care of Patients with Diabetes’. Diabetic Medicine 30.7 (2013): 803–817. Web.
Kamlesh Khunti. ‘Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes’. PLoS ONE 10.9 (2015): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556656/?report=classic>.
Kenneth Hodson. ‘Gestational Diabetes: Emerging Concepts in Pathophysiology’. Obstetric Medicine 3.4 (2010): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989628/?report=classic>.
Latika Sahu. ‘Comparison of the American Diabetes Association and World Health Organization Criteria for Gestational Diabetes Mellitus and the Outcomes of Pregnancy’. Obstetric Medicine 2.4 (2009): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989660/?report=classic>.
Lee, I-Min. ‘Physical Activity and Weight Gain Prevention’. JAMA 303.12 (2010): n. pag. Web.
Leelarathna, L. et al. ‘Comparison of Different Insulin Pump Makes under Routine Care Conditions in Adults with Type 1 Diabetes’. Diabetic Medicine 34.10 (2017): 1372–1379. Web.
Leff, D. R., and D. Heath. ‘Surgery for Obesity in Adulthood’. BMJ 339.sep22 1 (2009): b3402–b3402. Web.
Levin, Philip A et al. ‘Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review of Comparative Effectiveness Research’. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Volume 10 (2017): 123–139. Web.
‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’. New England Journal of Medicine 375.18 (2016): 1797–1799. Web.
‘Liraglutide for the Treatment of Type 2 Diabetes Mellitus. TA203, Oct 2010’. N.p., n.d. Web. <https://www.nice.org.uk/guidance/ta203>.
‘---’. N.p., n.d. Web. <https://www.nice.org.uk/guidance/ta203>.
‘Managing Older People with Type 2 Diabetes: IDF Global Guideline - International Federation on Ageing’. N.p., n.d. Web. <https://www.ifa-fiv.org/managing-older-people-with-type-2-diabetes-idf-global-guideline/>.
Marso, Steven P., Gilbert H. Daniels, et al. ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’. New England Journal of Medicine 375.4 (2016): 311–322. Web.
---. ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’. New England Journal of Medicine 375.4 (2016): 311–322. Web.
Marso, Steven P., Stephen C. Bain, et al. ‘Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes’. New England Journal of Medicine (2016): n. pag. Web.
‘Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence.  CG76, Jan 2009’. N.p., n.d. Web. <https://www.nice.org.uk/guidance/cg76>.
Merlin C. Thomas. ‘Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment’. Diabetes Therapy 7.3 (2016): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014795/>.
Min, Se Hee et al. ‘Comparison between SGLT2 Inhibitors and DPP4 Inhibitors Added to Insulin Therapy in Type 2 Diabetes: A Systematic Review with Indirect Comparison Meta-Analysis’. Diabetes/Metabolism Research and Reviews 33.1 (2017): n. pag. Web.
‘Minimizing Hypoglycemia in Diabetes: Table 1’. Diabetes Care 38.8 (2015): 1583–1591. Web.
Mishriky, Basem M., Doyle M. Cummings, and Robert J. Tanenberg. ‘The Efficacy and Safety of DPP4 Inhibitors Compared to Sulfonylureas as Add-on Therapy to Metformin in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis’. Diabetes Research and Clinical Practice 109.2 (2015): 378–388. Web.
Moreno-Castilla, Cristina, Didac Mauricio, and Marta Hernandez. ‘Role of Medical Nutrition Therapy in the Management of Gestational Diabetes Mellitus’. Current Diabetes Reports 16.4 (2016): n. pag. Web.
Narendran, P. et al. ‘Exercise to Preserve β-Cell Function in Recent-Onset Type 1 Diabetes Mellitus (EXTOD) - a Randomized Controlled Pilot Trial’. Diabetic Medicine 34.11 (2017): 1521–1531. Web.
‘National Obesity Observatory’. N.p., n.d. Web. <http://www.noo.org.uk>.
Nauck, M. A. et al. ‘Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Compared with the Sulfonylurea, Glipizide, in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Alone: A Randomized, Double-Blind, Non-Inferiority Trial’. Diabetes, Obesity and Metabolism 9.2 (2007): 194–205. Web.
Nauck, Michael et al. ‘Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)’. Diabetes Care 37.8 (2014): 2149–2158. Web.
Nauck, Michael A, and Juris J Meier. ‘The Incretin Effect in Healthy Individuals and Those with Type 2 Diabetes: Physiology, Pathophysiology, and Response to Therapeutic Interventions’. The Lancet Diabetes & Endocrinology 4.6 (2016): 525–536. Web.
‘NHS Evidence: An Introduction’. Web. <http://www.solent.nhs.uk/_store/documents/nhs_evidence_guide.pdf>.
Nissen, Steven E., and Kathy Wolski. ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’. New England Journal of Medicine 356.24 (2007): 2457–2471. Web.
Noctor, Eoin, and Fidelma Dunne. ‘Postnatal Testing Following Gestational Diabetes’. The Lancet Diabetes & Endocrinology 3.10 (2015): 761–762. Web.
Nolan, Christopher J. et al. ‘Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes’. Diabetes 64.3 (2015): 673–686. Web.
‘Obesity: Identification, Assessment and Management | Guidance and Guidelines | NICE’. n. pag. Web. <https://www.nice.org.uk/guidance/cg189>.
Paul Craddy. ‘Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison’. Diabetes Therapy 5.1 (2014): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065303/>.
Perrin, N. E. et al. ‘The Prevalence of Diabetes-Specific Emotional Distress in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis’. Diabetic Medicine 34.11 (2017): 1508–1520. Web.
Persaud, Shanta J., and Peter M. Jones. ‘A Wake-up Call for Type 2 Diabetes?’ New England Journal of Medicine 375.11 (2016): 1090–1092. Web.
Pickup, John C. ‘Insulin-Pump Therapy for Type 1 Diabetes Mellitus’. New England Journal of Medicine 366.17 (2012): 1616–1624. Web.
Qin, Li et al. ‘Does Physical Activity Modify the Risk of Obesity for Type 2 Diabetes: A Review of Epidemiological Data’. European Journal of Epidemiology 25.1 (2010): 5–12. Web.
Rasouli, B. et al. ‘Serious Life Events and the Risk of Latent Autoimmune Diabetes in Adults (LADA) and Type 2 Diabetes’. Diabetic Medicine 34.9 (2017): 1259–1263. Web.
Riddle, M. C. et al. ‘Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-Week, Randomized, Placebo-Controlled Comparison (GetGoal-L)’. Diabetes Care 36.9 (2013): 2489–2496. Web.
Rinki Murphy. ‘Monogenic Diabetes and Pregnancy’. Obstetric Medicine 8.3 (2015): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935018/>.
Rizos, Christos V., Anastazia Kei, and Moses S. Elisaf. ‘The Current Role of Thiazolidinediones in Diabetes Management’. Archives of Toxicology 90.8 (2016): 1861–1881. Web.
Rotz, M. E. et al. ‘Implications of Incretin-Based Therapies on Cardiovascular Disease’. International Journal of Clinical Practice 69.5 (2015): 531–549. Web.
Ryder, Bob et al. ‘ABCD Position Statement on GLP-1 Based Therapies and Pancreatic Damage’. Practical Diabetes 30.9 (2013): 388–391. Web.
S M Attard. ‘Implications of Iron Deficiency/Anemia on the Classification of Diabetes Using HbA1c’. Nutrition & Diabetes 5.6 (2015): n. pag. Web. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491857/>.
Sallis, James F et al. ‘Progress in Physical Activity over the Olympic Quadrennium’. The Lancet 388.10051 (2016): 1325–1336. Web.
Samuel, Varman T., and Gerald I. Shulman. ‘Intergrating Mechanisms  for Insulin Resistance: Common Threads and Missing Links’. Cell 148.5 (2012): 852–871. Web.
Schauer, Philip R., Deepak L. Bhatt, et al. ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’. New England Journal of Medicine 376.7 (2017): 641–651. Web.
---. ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’. New England Journal of Medicine 376.7 (2017): 641–651. Web.
Schauer, Philip R., Sangeeta R. Kashyap, et al. ‘Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes’. New England Journal of Medicine 366.17 (2012): 1567–1576. Web.
Schwartz, Stanley S. et al. ‘The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema’. Diabetes Care 39.2 (2016): 179–186. Web.
Sivasubramaniyam, S., S. A. Amiel, and P. Choudhary. ‘Proportion of Daily Capillary Blood Glucose Readings Required in the Target Range for Target Glycaemic Control: Shift of Focus from Target Range to Proportion in Range’. Diabetic Medicine 34.10 (2017): 1456–1460. Web.
Sjöström, Lars et al. ‘Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery’. New England Journal of Medicine 351.26 (2004): 2683–2693. Web.
Srinivasan, P et al. ‘Islet Cell Transplantation’. Postgraduate Medical Journal 83.978 (2007): 224–229. Web.
‘Standards of Medical Care in Diabetes--2015: Summary of Revisions’. Diabetes Care 38.Supplement_1 (2015): S4–S4. Web.
Steven, S., and R. Taylor. ‘Restoring Normoglycaemia by Use of a Very Low Calorie Diet in Long- and Short-Duration Type 2 Diabetes’. Diabetic Medicine 32.9 (2015): 1149–1155. Web.
Steven, Sarah et al. ‘Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders’. Diabetes Care 39.5 (2016): 808–815. Web.
Stewart, Zoe A. et al. ‘Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes’. New England Journal of Medicine 375.7 (2016): 644–654. Web.
Tanner, Michael. ‘Review: In Type 2 Diabetes, Adding Dipeptidyl Peptidase-4 Inhibitors to Sulphonylureas Increases Hypoglycemia’. Annals of Internal Medicine 165.4 (2016): n. pag. Web.
Tao, L. et al. ‘Cost-Effectiveness of Intensive Multifactorial Treatment Compared with Routine Care for Individuals with Screen-Detected Type 2 Diabetes: Analysis of the ADDITION-UK Cluster-Randomized Controlled Trial’. Diabetic Medicine 32.7 (2015): 907–919. Web.
The Eatwell Guide. Public Health England, 2016. Web. <https://www.gov.uk/government/publications/the-eatwell-guide>.
‘Type 2 Diabetes in Adults: Management | Guidance and Guidelines | NICE’. n. pag. Web. <https://www.nice.org.uk/guidance/ng28>.
‘Type 2 Diabetes: Lixisenatide | Evidence-Review | Advice | NICE’. n. pag. Web. <https://www.nice.org.uk/advice/esnm26/chapter/evidence-review>.
‘Type 2 Diabetes: Prevention in People at High Risk | Guidance and Guidelines | NICE’. n. pag. Web. <http://www.nice.org.uk/guidance/PH38>.
Umpierre, Daniel. ‘Physical Activity Advice Only or Structured Exercise Training and Association With HbA                              Levels in Type 2 Diabetes’. JAMA 305.17 (2011): n. pag. Web.
‘Unit 3 – Special Care Groups: A Practical Guide to Pregnancy Complicated by Diabetes - Diabetes & Primary Care’. N.p., n.d. Web. <http://www.diabetesandprimarycare.co.uk/journal-content/view/unit-3-special-care-groups-a-practical-guide-to-pregnancy-complicated-by-diabetes/?preview>.
Villani, M., B. de Courten, and S. Zoungas. ‘Emergency Treatment of Hypoglycaemia: A Guideline and Evidence Review’. Diabetic Medicine 34.9 (2017): 1205–1211. Web.
Vloemans, A. F. et al. ‘Keeping Safe. Continuous Glucose Monitoring (CGM) in Persons with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia: A Qualitative Study’. Diabetic Medicine 34.10 (2017): 1470–1476. Web.
Wanner, Christoph et al. ‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’. New England Journal of Medicine 375.4 (2016): 323–334. Web.
William H. Polonsky,Lawrence Fisher,Jay Earles,R. James Dudl,Joel Lees,Joseph Mullan. ‘Assessing Psychosocial Distress in Diabetes: Development of the Diabetes Distress Scale’. Diabetes Care n. pag. Web. <http://go.galegroup.com.ezproxy3.lib.le.ac.uk/ps/retrieve.do?tabID=T002&amp;resultListType=RESULT_LIST&amp;searchResultsType=SingleTab&amp;searchType=AdvancedSearchForm&amp;currentPosition=25&amp;docId=GALE%7CA130282980&amp;docType=Article&amp;sort=Relevance&amp;contentSegment=&amp;prodId=EAIM&amp;contentSet=GALE%7CA130282980&amp;searchId=R15&amp;userGroupName=leicester&amp;inPS=true>.
Yates, T., and M. J. Davies. ‘Physical Activity and Type 1 Diabetes: An Underused Therapy’. Diabetic Medicine 34.11 (2017): 1498–1499. Web.
Yeh, James S., Robert F. Kushner, and Gordon D. Schiff. ‘Obesity and Management of Weight Loss’. New England Journal of Medicine 375.12 (2016): 1187–1189. Web.
Young-Hyman, Deborah et al. ‘Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140’. Diabetes Care 40.2 (2017): 287.1-287. Web.
Zaccardi, Francesco et al. ‘Pathophysiology of Type 1 and Type 2 Diabetes Mellitus: A 90-Year Perspective’. Postgraduate Medical Journal 92.1084 (2016): 63–69. Web.